FDA regulation

Leucovorin for Autism Spectrum Disorder: Navigating Clinical Efficacy and Regulatory Controversy

This article evaluates the clinical evidence supporting leucovorin for autism spectrum disorder and examines the FDA’s controversial proposal to expand its indications based on mechanistic data rather than traditional large-scale clin

Evidence-Based Evolution: How FDA Scientists Shielded Mifepristone Regulation From Political Interference